SCHEMBL24908333

SCHEMBL24908333

Bc1c(B)c(B)c2c(-c3ccc4oc5cc6ccccc6cc5c4c3)c3c(B)c(B)c(B)c(B)c3c(-c3cccc(-c4ccc5ccc6ccccc6c5c4)c3)c2c1B

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
KDM4E B2RXH2 7/20 0.38
MAPT P10636 5/20 0.38
HSD17B10 Q99714 3/20 0.38
HPGD P15428 3/20 0.38
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
GLA P06280 2/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
ESR1 P03372 1/20 0.36
POLB P06746 1/20 0.36
HNF4A P41235 1/20 0.36
PLA2G10 O15496 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24766815 0.95 KDM4E (0.37) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24908221 0.94 KDM4E (0.37) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL25789710 0.93 HSD17B1 (0.37) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26010882 0.91 PLA2G2A (0.38) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24908330 0.90 PLA2G2A (0.37) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL25789641 0.89 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24908327 0.89 KDM4E (0.36) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24908177 0.89 KDM4E (0.36) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24908331 0.89 MAPT (0.36) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24908230 0.88 ALDH1A1 (0.34) ALDH1A1KDM4EMAPTHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS MRPS22, RER1, EMC2 ALDH1A1 1929/4885KDM4E 2476/4885MAPT 3554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.